Feed NOMD
NO

Nomad Foods NOMD · NYSE

$12.20 +3.35% (+$0.40)

Summary

50 / 100 · Bulios Score

What speaks for it

  • It bought back its own shares for 202.5M € in the last fiscal year, 14% of its market value.
  • It has been profitable 6 years in a row.

What to watch

  • Repaying its net debt would take 6.0 years of operating profit.
  • The share price is above the Bulios Fair Price.
  • Earnings per share fell by 14% a year over the last 3 years.
  • It earns only 6.0 EUR a year on every 100 EUR of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $12.2
P/E today 11.7 17% lower
5-year average P/E 14.0
P/E today 11.7
Packaged Foods industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 11.7 EUR for 1 EUR of yearly profit. Over the last five years it was 14.0 EUR on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue grew by 3.8% a year over 5 years. Over the last 3 years it grew by 1.0% a year. Earnings per share fell by 14% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 EUR of revenue goes

Net profit, industry median (Packaged Foods) 5.7 EUR

Out of every 100 EUR of revenue, 4.2 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 11.3 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, stretched
Yield
5.76%
Paid out of profit
67%
Raised in a row
1 year

You receive $0.68 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $12.5 is 2.5% above today's price. 77% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

The company reports no revenue by product.

By region

Rest Of Europe brings in 18% of revenue. CROATIA grew fastest, by 5.9% a year.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.